Vmn1r20 Inhibitors
Vmn1r20, a vomeronasal receptor predicted to play a crucial role in pheromone binding and reception, is integral to the intricate sensory mechanisms underlying chemosensory communication. While specific inhibitors for Vmn1r20 remain elusive, the identified compounds offer insights into potential modulators that may indirectly regulate its function. The envisioned inhibition strategies encompass a spectrum of compounds targeting diverse cellular processes. Gallein, a GPCR inhibitor, and pertussis toxin, inhibiting Gi/o proteins, directly intervene in G protein signaling pathways associated with Vmn1r20, potentially influencing its response to pheromones. Additionally, modulators like cycloheximide and BAPTA-AM indirectly impact Vmn1r20 by altering protein synthesis or intracellular calcium concentrations, respectively.
The complexity of Vmn1r20's function is further elucidated by compounds like LY294002, a PI3K inhibitor, and PD98059, a MEK inhibitor, suggesting potential crosstalk with intracellular signaling cascades. Calcium-dependent modulators such as U73122 and KN-93 highlight the importance of calcium signaling in Vmn1r20 activity, while tetrodotoxin, a sodium channel blocker, implicates neuronal excitability in pheromone reception. In summary, while specific inhibitors for Vmn1r20 remain undiscovered, the array of compounds targeting various cellular processes provides a foundation for understanding the intricate regulatory mechanisms governing vomeronasal receptor activity. Exploring these potential inhibitors not only reveals insights into Vmn1r20's role in chemosensory perception but also sets the stage for further investigations into the dynamic interplay of signaling pathways that govern pheromone reception.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Clomiphene Citrate | 50-41-9 | sc-205636 sc-205636A | 1 g 5 g | $84.00 $176.00 | 1 | |
Clomiphene, an estrogen receptor modulator, may indirectly impact Vmn1r20 by influencing hormonal signaling pathways. As a potential endocrine disruptor, clomiphene could alter the regulation of pheromone receptors, affecting their binding activity and downstream responses. | ||||||
Gallein | 2103-64-2 | sc-202631 | 50 mg | $85.00 | 20 | |
Gallein, a G protein-coupled receptor (GPCR) inhibitor, may directly interfere with GPCR signaling pathways associated with Vmn1r20. By inhibiting downstream cascades, gallein could disrupt pheromone receptor activity, influencing the sensory processes governed by Vmn1r20. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide, a protein synthesis inhibitor, may impact Vmn1r20 indirectly by influencing the synthesis of proteins involved in pheromone signaling. Disruption of protein synthesis could modulate the expression or function of components essential for proper Vmn1r20 activity. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM, a calcium chelator, may directly affect Vmn1r20 by altering intracellular calcium concentrations. Given the importance of calcium signaling in pheromone responses, BAPTA-AM could disrupt the receptor's activity by modulating calcium-dependent processes. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin, an inhibitor of Gi/o proteins, may directly interfere with G protein signaling pathways linked to Vmn1r20. By blocking Gi/o proteins, pertussis toxin could disrupt downstream signaling events, potentially influencing the pheromone receptor activity of Vmn1r20. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a phosphoinositide 3-kinase (PI3K) inhibitor, may directly impact Vmn1r20 by interfering with PI3K-dependent signaling pathways. As PI3K signaling is implicated in various cellular processes, LY294002 could modulate the pheromone receptor activity and downstream responses of Vmn1r20. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Suramin, a GPCR antagonist, may directly interfere with Vmn1r20 by inhibiting GPCR signaling pathways. By blocking GPCR activation, suramin could disrupt downstream cascades, potentially affecting the pheromone binding and receptor activity of Vmn1r20. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93, a calcium/calmodulin-dependent protein kinase II (CaMKII) inhibitor, may directly impact Vmn1r20 by interfering with CaMKII-dependent signaling pathways. As CaMKII is involved in calcium-mediated signaling, KN-93 could modulate the pheromone receptor activity of Vmn1r20 by affecting downstream events. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor, may indirectly influence Vmn1r20 by disrupting the MAPK/ERK signaling pathway. As this pathway is implicated in GPCR signaling, PD98059 could modulate downstream events, potentially affecting the pheromone receptor activity and responses of Vmn1r20. | ||||||